Great news that more institutions are recognising tassals current and future value! http://www.barrons.com/articles/tassal-why-goldman-sachs-says-buy-1496646724
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025